[EN] N-CYCL0ALKYLMETHYL-2-AMIN0THIAZ0LE-5-CARB0XAMIDES FOR USE IN PLANT DISEASE CONTROL [FR] COMPOSÉS AMIDES ET LEUR UTILISATION POUR LUTTER CONTRE UNE MALADIE DE PLANTE
Process for making 1-cyclopentylalyl amines useful for the synthesis of
申请人:The Coca-Cola Company
公开号:US05225591A1
公开(公告)日:1993-07-06
The disclosed process relates to a method for preparing 1-cyclopentylalkyl amines, useful in the synthesis of artificial sweeteners, by reducing an azanorbornene in a high-yield one-step reduction of an azanorbornene, wherein the method involves use of a solvent reductant system with catalyst that is compatible with the production of edible food compositions.
AMIDE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL
申请人:Komori Takashi
公开号:US20100298391A1
公开(公告)日:2010-11-25
The present invention provides an amide compound represented by the formula (1):
wherein R
1
and R
2
independently represent a hydrogen atom or a methyl group; and Cy
1
represents a C3-C6 cycloalkyl group, said compound having excellent plant disease controlling effect.
Quinazoline compounds as modulators of Ras signaling
申请人:VANDERBILT UNIVERSITY
公开号:US11318137B2
公开(公告)日:2022-05-03
The present invention relates to quinazoline compounds and compositions that modulate Ras signaling. Compounds and compositions of the present invention are useful in the treatment of cancers and other disease states associated with Ras dysfunction (e.g., Ras-associated autoimmune leukoproliferative disorder, or certain types of mitochondrial dysfunction) in a subject, for example a mammal or a human.
N-CYCL0ALKYLMETHYL-2-AMIN0THIAZ0LE-5-CARB0XAMIDES FOR USE IN PLANT DISEASE CONTROL
申请人:Sumitomo Chemical Company, Limited
公开号:EP2222655A1
公开(公告)日:2010-09-01
QUINAZOLINE COMPOUNDS AS MODULATORS OF RAS SIGNALING
申请人:VANDERBILT UNIVERSITY
公开号:US20200253974A1
公开(公告)日:2020-08-13
The present invention relates to quinazoline compounds and compositions that modulate Ras signaling. Compounds and compositions of the present invention are useful in the treatment of cancers and other disease states associated with Ras dysfunction (e.g., Ras-associated autoimmune leukoproliferative disorder, or certain types of mitochondrial dysfunction) in a subject, for example a mammal or a human.